Downgrades Buy Neutral X

ESTA Establishment Labs

Citigroup

$60

Initiated Overweight X

ESTA Establishment Labs

JP Morgan

$75

Initiated Buy X

ESTA Establishment Labs

Citigroup

$79

Resumed Overweight X

ESTA Establishment Labs

Stephens

$90

Initiated Buy X

ESTA Establishment Labs

Mizuho

$70

Initiated Buy X

ESTA Establishment Labs

B. Riley Securities

$107

Initiated Outperform X

ESTA Establishment Labs

Wells Fargo

$29

Initiated Overweight X

ESTA Establishment Labs

Stephens

$37

Initiated Buy X

ESTA Establishment Labs

Jefferies

$35

ESTA  Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc., a medical technology company, designs, develops, manufactures, and markets medical devices for aesthetic plastic surgery, reconstructive plastic surgery, and aesthetic dermatology. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue. The company sells its products through exclusive distributors and direct sales force in 60 countries worldwide. Establishment Labs Holdings Inc. was founded in 2004 and is headquartered in Alajuela, Costa Rica.